August 15, 2025VaccinesOpen Access

Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination

View Full Paper

Ask AI

Bookmark

Authors

HPHeiko PfisterDeutsches Herzzentrum München CUCarsten UhligCenter for Evaluation and Development ZMZsuzsanna MayerDeutsches Herzzentrum München

Discussion

Member takes

Implication

Observational cohort study finds balanced immunity to conserved and non-conserved Spike epitopes enhances protection against symptomatic Omicron infections.

Key Points

Long-term protection against symptomatic Omicron infections requires a balanced immune response to both conserved and non-conserved Spike epitopes.
Neutralizing antibody levels served as a reliable correlate of protection prior to booster, yet diminished thereafter, highlighting post-boost immune remodeling.
The study utilized an observational cohort design, analyzing neutralizing antibody levels and cellular immunity in 107 subjects 6 months post-vaccination and booster.
These findings imply that future vaccines targeting both conserved and non-conserved epitopes may offer better long-term protection against symptomatic infections.

Cite This Study

Pfister et al. (2025) studied this question.

synapsesocial.com/papers/68af5407ad7bf08b1eadad92 https://doi.org/10.3390/vaccines13080867

View Full Paper

Ask AI

Bookmark

Implication

Observational cohort study finds balanced immunity to conserved and non-conserved Spike epitopes enhances protection against symptomatic Omicron infections.

Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination

Discussion

Member takes

Implication

Key Points

Cite This Study

Long-Term Protection Against Symptomatic Omicron Infections Requires Balanced Immunity Against Spike Epitopes After COVID-19 Vaccination

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider